메뉴 건너뛰기




Volumn 1, Issue 3, 2000, Pages 143-145

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?

Author keywords

Aspirin; Cerebral ischaemia; Clopidogrel; Myocardial infarction; Peripheral artery disease

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PLACEBO; PYRIDINE DERIVATIVE; THROMBOCYTE RECEPTOR; TICLOPIDINE;

EID: 0034467769     PISSN: 14686708     EISSN: None     Source Type: Journal    
DOI: 10.1186/CVM-1-3-143     Document Type: Note
Times cited : (6)

References (15)
  • 1
    • 0030590746 scopus 로고    scopus 로고
    • CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).
    • (1996) Lancet , vol.348 , pp. 1329-1339
  • 2
    • 0005781953 scopus 로고    scopus 로고
    • Summary Proceedings KG 00/758 (26 July 2000) and KG 00/993 (4 August 2000). The Hague: District Court
    • (2000)
  • 3
    • 0028120906 scopus 로고
    • AntiPlatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in patients
    • (1994) BMJ , vol.308 , pp. 81-106
  • 4
    • 0033933641 scopus 로고    scopus 로고
    • Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials
    • (2000) Stroke , vol.31 , pp. 1779-1784
    • Hankey, G.J.1    Sudlow, C.L.2    Dunbabin, D.W.3
  • 5
    • 0005820436 scopus 로고    scopus 로고
    • Thienopyridine Derivatives (Ticlopidine, Clopidogrel) versus Aspirin in Preventing Stroke and Other Serious Vascular Events in High Vascular Risk Patients, issue 2, update software. Oxford, UK: The Cochrane Library
    • (2000)
    • Hankey, G.J.1    Sudlow, C.L.2    Dunbabin, D.W.3
  • 9
    • 0034702540 scopus 로고    scopus 로고
    • Clopidogrel and thrombotic thrombocytopenic purpura
    • (2000) Lancet , vol.356 , pp. 269-270
    • Hankey, G.J.1
  • 10
    • 0034646201 scopus 로고    scopus 로고
    • Choice of endpoints in antiplatelet trials: Which outcomes are most relevant to stroke patients?
    • (2000) Neurology , vol.54 , pp. 1022-1028
    • Albers, G.W.1
  • 11
    • 0031455701 scopus 로고    scopus 로고
    • The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group: A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin.
    • (1997) Ann Neurol , vol.42 , pp. 857-865
  • 12
    • 0033598606 scopus 로고    scopus 로고
    • Treatment and secondary prevention of stroke: Evidence, costs, and effects on individuals and populations
    • (1999) Lancet , vol.354 , pp. 1457-1463
    • Hankey, G.J.1    Warlow, C.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.